Literature DB >> 7686345

Regulation of complement membrane attack complex formation in myocardial infarction.

A Väkevä1, P Laurila, S Meri.   

Abstract

Recent studies have suggested that the complement (C) system is involved in the development of tissue injury of myocardial infarction. As it is not known why the strictly controlled C system starts to react against autologous heart tissue, we have analyzed the expression of various membrane regulators of C (CR1, DAF, MCP, CD59, C8 binding protein) and the pattern of deposition of C components and plasma C regulators (C4b binding protein and vitronectin) in normal (n = 7) and infarcted (n = 13) human myocardium. In the infarcted myocardium deposits of the C membrane attack complex (MAC) were observed by immunofluorescence microscopy, and lesions resembling the transmembrane channels of MAC were detected by transmission electron microscopy. CD59 and C8 binding protein were strongly expressed by muscle cells of normal myocardial tissue. Little or no CR1, MCP, and DAF was observed on these cells. The assembly of MAC was accompanied by the deposition of vitronectin (S-protein) and C4b binding protein in the infarcted areas of myocardium. In accordance with our earlier results the expression of CD59 but not of C8 binding protein was clearly diminished in the lesions. The results show that C8 binding protein, vitronectin, and C4b binding protein do not prevent complement attack against the infarcted myocardium but rather become codeposited with the MAC. Ischemia-induced transformation of nonviable cells into complement activators, acquired loss of resistance to the MAC by shedding of CD59, and recruitment of multifunctional serum proteins by MAC could thus constitute a general process aimed at the clearance of injured tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686345      PMCID: PMC1886952     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.

Authors:  K Whaley; S Ruddy
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Improved mountant for immunofluorescence preparations.

Authors:  G V Heimer; C E Taylor
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

4.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Isolation of human S-protein, an inhibitor of the membrane attack complex of complement.

Authors:  E R Podack; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

6.  Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.

Authors:  R N Pinckard; M S Olson; P C Giclas; R Terry; J T Boyer; R A O'Rourke
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.

Authors:  P R Maroko; C B Carpenter; M Chiariello; M C Fishbein; P Radvany; J D Knostman; S L Hale
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Complement localization and mediation of ischemic injury in baboon myocardium.

Authors:  R N Pinckard; R A O'Rourke; M H Crawford; F S Grover; L M McManus; J J Ghidoni; S B Storrs; M S Olson
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein.

Authors:  B Dahlbäck; J Stenflo
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Human C4-binding protein. I. Isolation and characterization.

Authors:  J Scharfstein; A Ferreira; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

2.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

3.  Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model.

Authors:  B H M Heijnen; I H Straatsburg; N D Padilla; G J Van Mierlo; C E Hack; T M Van Gulik
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

4.  Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.

Authors:  Y T Konttinen; A Ceponis; S Meri; A Vuorikoski; P Kortekangas; T Sorsa; A Sukura; S Santavirta
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

5.  Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis.

Authors:  Bing Li; Mei-Hua Gao; Xian-Ming Chu; Ying-Jie Xu; Fan Yang
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

6.  Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion.

Authors:  M Närkiö-Mäkelä; J Jero; S Meri
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

7.  Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model.

Authors:  Ming Zhang; Elisabeth M Alicot; Michael C Carroll
Journal:  Mol Immunol       Date:  2008-07-30       Impact factor: 4.407

8.  Validation of the vitronectin knockout mouse as a model for studying myocardial infarction: Vitronectin appears to influence left ventricular remodelling following myocardial infarction.

Authors:  Gordon E Pate; Hubert P Walinski; Lubos Bohunek; Thomas J Podor
Journal:  Exp Clin Cardiol       Date:  2013

9.  The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells.

Authors:  K S Kilgore; C M Flory; B F Miller; V M Evans; J S Warren
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

10.  Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.

Authors:  Gongxiong Wu; Weiguo Hu; Aliakbar Shahsafaei; Wenping Song; Martin Dobarro; Galina K Sukhova; Rod R Bronson; Guo-Ping Shi; Russell P Rother; Jose A Halperin; Xuebin Qin
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.